IQVIA (IQV) Competitors $157.71 -2.42 (-1.51%) Closing price 07/15/2025 03:59 PM EasternExtended Trading$157.74 +0.03 (+0.02%) As of 07/15/2025 07:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IQV vs. BRKR, ICLR, MEDP, TECH, A, CRL, DHR, MTD, TMO, and WATShould you be buying IQVIA stock or one of its competitors? The main competitors of IQVIA include Bruker (BRKR), Icon (ICLR), Medpace (MEDP), Bio-Techne (TECH), Agilent Technologies (A), Charles River Laboratories International (CRL), Danaher (DHR), Mettler-Toledo International (MTD), Thermo Fisher Scientific (TMO), and Waters (WAT). IQVIA vs. Its Competitors Bruker Icon Medpace Bio-Techne Agilent Technologies Charles River Laboratories International Danaher Mettler-Toledo International Thermo Fisher Scientific Waters IQVIA (NYSE:IQV) and Bruker (NASDAQ:BRKR) are related companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership. Do analysts rate IQV or BRKR? IQVIA currently has a consensus price target of $222.45, suggesting a potential upside of 41.05%. Bruker has a consensus price target of $52.89, suggesting a potential upside of 26.05%. Given IQVIA's stronger consensus rating and higher probable upside, research analysts plainly believe IQVIA is more favorable than Bruker.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IQVIA 0 Sell rating(s) 7 Hold rating(s) 16 Buy rating(s) 1 Strong Buy rating(s) 2.75Bruker 0 Sell rating(s) 6 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.40 Do insiders & institutionals have more ownership in IQV or BRKR? 89.6% of IQVIA shares are held by institutional investors. Comparatively, 79.5% of Bruker shares are held by institutional investors. 1.6% of IQVIA shares are held by insiders. Comparatively, 27.3% of Bruker shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has better earnings and valuation, IQV or BRKR? IQVIA has higher revenue and earnings than Bruker. IQVIA is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIQVIA$15.41B1.77$1.37B$7.3421.49Bruker$3.45B1.85$113.10M$0.5280.69 Which has more risk & volatility, IQV or BRKR? IQVIA has a beta of 1.3, meaning that its share price is 30% more volatile than the S&P 500. Comparatively, Bruker has a beta of 1.18, meaning that its share price is 18% more volatile than the S&P 500. Does the media favor IQV or BRKR? In the previous week, IQVIA had 16 more articles in the media than Bruker. MarketBeat recorded 23 mentions for IQVIA and 7 mentions for Bruker. Bruker's average media sentiment score of 1.16 beat IQVIA's score of 0.98 indicating that Bruker is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IQVIA 13 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Bruker 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is IQV or BRKR more profitable? IQVIA has a net margin of 8.61% compared to Bruker's net margin of 2.31%. IQVIA's return on equity of 29.16% beat Bruker's return on equity.Company Net Margins Return on Equity Return on Assets IQVIA8.61% 29.16% 6.96% Bruker 2.31%19.47%5.95% SummaryIQVIA beats Bruker on 13 of the 17 factors compared between the two stocks. Get IQVIA News Delivered to You Automatically Sign up to receive the latest news and ratings for IQV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IQV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IQV vs. The Competition Export to ExcelMetricIQVIAMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$27.70B$6.83B$5.62B$20.84BDividend YieldN/A1.28%4.25%3.65%P/E Ratio21.4925.9728.5727.17Price / Sales1.7761.62423.3548.17Price / Cash9.6420.3636.0222.28Price / Book4.724.638.134.56Net Income$1.37B$174.76M$3.24B$995.22M7 Day Performance-2.73%-3.25%0.16%-1.16%1 Month Performance-1.00%-0.33%5.95%3.18%1 Year Performance-32.30%0.36%26.09%6.83% IQVIA Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IQVIQVIA4.9182 of 5 stars$157.71-1.5%$222.45+41.1%-30.2%$27.70B$15.41B21.4988,000Upcoming EarningsBRKRBruker4.9782 of 5 stars$41.27-2.8%$52.89+28.2%-33.8%$6.25B$3.37B79.3711,396Positive NewsHigh Trading VolumeICLRIcon4.4303 of 5 stars$147.59-1.7%$213.08+44.4%-57.3%$11.92B$8.19B16.0841,900Upcoming EarningsMEDPMedpace4.233 of 5 stars$318.90-0.8%$344.82+8.1%-29.6%$9.17B$2.11B24.345,900Upcoming EarningsTECHBio-Techne4.8693 of 5 stars$51.53-3.0%$72.00+39.7%-33.4%$8.08B$1.16B62.843,100AAgilent Technologies4.7718 of 5 stars$119.21-1.8%$140.92+18.2%-13.6%$33.86B$6.51B29.4317,900CRLCharles River Laboratories International4.8115 of 5 stars$153.93-2.0%$171.85+11.6%-28.6%$7.56B$4.05B-236.8220,100Positive NewsDHRDanaher4.97 of 5 stars$199.60-1.8%$248.61+24.6%-21.7%$142.85B$23.88B38.7663,000Positive NewsUpcoming EarningsMTDMettler-Toledo International3.9716 of 5 stars$1,188.28-1.7%$1,300.36+9.4%-14.2%$24.69B$3.87B29.6317,300Positive NewsTMOThermo Fisher Scientific4.991 of 5 stars$418.76-2.5%$604.05+44.2%-23.1%$158.08B$42.88B24.56125,000Positive NewsUpcoming EarningsDividend AnnouncementWATWaters4.8761 of 5 stars$346.35-1.1%$388.00+12.0%-4.3%$20.61B$2.96B31.437,600Trending NewsAnalyst Forecast Related Companies and Tools Related Companies Bruker Alternatives Icon Alternatives Medpace Alternatives Bio-Techne Alternatives Agilent Technologies Alternatives Charles River Laboratories International Alternatives Danaher Alternatives Mettler-Toledo International Alternatives Thermo Fisher Scientific Alternatives Waters Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:IQV) was last updated on 7/16/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IQVIA Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IQVIA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.